David James Lennon, CHIEF EXECUTIVE OFFICER at Whitehawk Therapeutics, Inc. (WHWK), sold 260,427 shares at $3.51 ($900K) on 2026-04-06, disclosed to the SEC on 2026-04-08.
Open-market sale of $900k WHWK by CHIEF EXECUTIVE OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.51 | 102,395 | $359K | 40.0% |
| 2 | $3.43 | 94,087 | $323K | 35.9% |
| 3 | $3.40 | 63,945 | $217K | 24.2% |
| Total | $3.45 avg | 260,427 | $900K | 100% |
| Filing → |
| WHWK | SELL | 2026-03-10 | $17K | — | Filing → |
| AADI | SELL | 2025-03-03 | $13K | — | Filing → |
| AADI | SELL | 2024-10-03 | $19K | — | Filing → |